Forest Laboratories, Inc.Frank J. Murdolo, 1-212-224-6714Vice President - Investor RelationsorSard Verbinnen & CoHugh Burns/Renee Soto/Lesley Bogdanow1-212-687-8080orMacKenzie PartnersDan Burch, 1-212 ...
NEW YORK--Forest Laboratories, Inc. (NYSE: FRX) today issued the following statement in response to a Form 13D filing with the Securities and Exchange Commission (SEC) by High River Limited ...
NEW YORK, Jun 13, 2011 (BUSINESS WIRE) -- Forest Laboratories, Inc. (NYSE: FRX) today announced that it has received notice from High River Limited Partnership, an entity affiliated with Carl C. Icahn ...
Forest Laboratories, Inc. (NYSE:FRX), a leading, fully integrated, specialty pharmaceutical company, today announced the completion of its acquisition of Aptalis, a privately held specialty ...
Forest Laboratories' (NYSE: FRX) longstanding global partnerships and track record developing and marketing pharmaceutical products in the United States have yielded its well-established central ...
NEW YORK--(BUSINESS WIRE)--BUDAPEST, Hungary, June, 29, 2010-- Forest Laboratories, Inc. (NYSE: FRX) and Gedeon Richter Plc. today announced top-line results from a Phase II placebo and positive ...
AACHEN, Germany & NEW YORK--(BUSINESS WIRE)-- The Gruenenthal Group and Forest Laboratories, Inc. (NYSE: FRX), today announced that Gruenenthal GmbH and Forest Laboratories Ireland Limited, a wholly ...
After one of his sons fell into a deep depression, he helped him recover. He later licensed an antidepressant that was a boon to his pharmaceutical company. By Richard Sandomir Months ago, Mr. Icahn ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results